Cupid Ltd is hereby informing BSE about Un-audited Financial Results (Standalone & Consolidated) for the Quarter ended June 30, 2026

Date: August 07, 2026 BSE Limited, The National Stock Exchange of India Ltd, Phiroze Jeejeebhoy Towers, “Exchange Plaza”, 5th Floor, Dalai Street, Bandra - Kurla Complex, Bandra (East), Mumbai - 400 001 Mumbai - 400051 Scrip Code: 530843 Symbol: CUPID Subject: Outcome of Board Meeting held on August 07, 2026 and Un-audited Financial Results for Quarter ended June 30, 2026. Dear Sir / Madam, With reference to captioned subject, we attached herewith the detail statement of outcome of Board Meeting and Financial Results for quarter ended 30th June, 2026 pursuant to regulation 30 and regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) respectively. This intimation is also being uploaded on the Company’s website at https://www.cupidlimited.com/ You are requested to take the aforesaid information on your records. For Cupid Limited Hardik Chandra Company Secretary and Compliance Officer Encl: As above OUTCOME OF BOARD MEETING August 7, 2026: The Board of Directors of Cupid Limited at its Meeting held on August 07, 2026, inter alia, had considered and approved the following matters: - Commencement time of Board Meeting: - 04.15 P.M. Conclusion time of Board Meeting: - 05.03 P.M. 1. Quarterly reports submitted to BSE Limited and National Stock Exchange of India Limited for quarter ended 30th June, 2026 were noted by the Board. 2. Un-audited Financial results (Standalone and Consolidated) of the Company for quarter ended 30th June, 2026 were considered and adopted by the Board. A copy of the Un-audited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2026, including disclosures required under Regulations 33 and other provisions of the SEBI Listing Regulations as applicable, together with the Limited Review Report issued by Chaturvedi Sohan & Co., Chartered Accountants (Firm Registration Number: 118424W), the Statutory Auditors of the Company, is enclosed herewith. 3. KPMSS & Associates, Cost Accountants, re-appointed as Cost Auditors of the company for Financial Year 2026-27 as per the provisions of Section 148 of the Companies Act, 2013. (Details as attached – Annexure - II) 4. In-principle approval for undertaking an exploratory exercise to evaluate the establishment of the Company’s proposed business project in the State of West Bengal, including assessment of land and infrastructure availability, and commercial and financial feasibility. The proposed project may be undertaken through the Company or a 100% Wholly Owned Subsidiary (WOS) to be incorporated, and shall, subject to necessary approvals, undertake the manufacturing, processing, marketing, trading and distribution of medical devices, healthcare products and other related products, together with such allied, ancillary or diversified business activities as may be approved by the Board from time to time and are consistent with the Company’s business objectives. The disclosures required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 (as amended from time to time), shall be made upon finalization of the proposed project and, where applicable, upon incorporation of the Wholly Owned Subsidiary (WOS) and execution of definitive project-related arrangements. 5. Continuation of directorship of Mr. Thallapaka Venkateswara Rao (DIN: 05273533) as a Non- Executive Independent Director of the Company post attaining the age of 75 years, subject to the approval of Shareholders by way of Special Resolution at ensuing Annual General Meeting. 6. The Directors Report for year ended 31st March, 2026 was considered and approved by the Board. 7. The Notice to Members / Shareholders for 33rd Annual General Meeting of the company was considered and approved by the Board. Place: - Mumbai By the order of the Board of Directors Date: - August 07, 2026 For Cupid Limited Hardik Chandra Company Secretary and Compliance Officer Cupid Limited CIN No : L25193MH1993PLC070846 Regd. Office :- A-68, M.LD.C. (Malegaon), Sinnar, Nashik — 422113, Maharashtra, India. Ph:- 02551-230280, Fax:- 02551-230279, Website: www.cupidlimited.com, Email- info@cupidlimited.com Statement of Unaudited Standalone Financial Results for the Quarter Ended 30th June, 2026 (in Lacs except EPS data , unless otherwise stated) Quarter Ended On Year Ended on S-No. Particulars 30-Jun-2026 | 31-Mar-2026| 30-Jun-2025 | 31-Mar-2026 (Unaudited) | (Audited) | (unaudited) | (Audited) 1 |Revenue from operation 1547150 | 11.996.17 5.980.49 3577088 2 [2(a) Other Non - operation Incomes 230.16 32663 494.19 174053 2(b) Change in Fair Value of Investment (3.65) 881.56 5 1.628.73 Total Income 1569801 | 13.204.36 6,474.68 39,140.14 3 [Expenses a) | Cost of Material Consumed 1,869.92 5293.13 1.633.72 11,147.44 v | Purchase of Stock-In-Trade 2,045.10 837.67 5.985.97 o) | Change in Inventories (1.871.67) (62.05) (2.318.98) @) | Employee benefit expenses 881.34 71099 3,182.05 o) | Finance costs 87.24 6220 280.73 0 | Depreciation 127.36 12427 o) | Other Expenses 1.896.68 121171 Total Expenses 9,704.80 8,459.18 451851 4 [Profit from Continuing Operation Before 599321 A48 195617 i§249:67 Exceptional items and Taxes 5_[Profit From Ordinary Activities Before Tax 599321 474518 1,956.17 14,249.67 6 | Less: Tax Expenses a) Income tax for current quarter/ ycar 1.462.49 101337 51201 323213 b Short / (Excess) provision of carlicr years 93.17 8 : - B} Deferred Tax Expenses / (Credit) 2133 105.54 (57.61) 191.10 7 [NetEraRcA(Lose) pout Opdisney fedviles 441621 362627 1,501.77 10,826.44 after tax for the period 5 |Other Comprehensive Income / (Loss) (Net of Tax) a) Item that will not be reclassified to profit and loss & account iy [Remeasurement of employee defined beneiit i 140 . aam) obligation iy [Eauity nstrument through Other Comprehensive 5:63) . 570 Income 5 [Fotal Comprehensive Income (after tax) for the p—— 150177 S081543 period 1o |Paid up Equity Share Capital 1344661 | 13,446.61 1342335 13,446.61 (Face value Rs. 1/-) 11 [Earning Per Share (EPS) (*Not Annualised) (a)| BasicEPS (Amountis 7) 0.33 027+ 011+ (b) | Diluted EPS (Amount is 2) 0.32+ 0.26* 0.10* (Restated) Explanatory Notes to the Standalone Financial Results: - 1. The unaudited Standalone financial results for the quarter ended June 30, 2026 have been presented based on the information complied by the management in accordance with the Indian Accounting Standards (Ind AS) notified under section 133 of the Companies Act 2013 ( the Act) read with relevant rules issued there under and in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations), as amended. 2. The above Unaudited Standalone financial results of Cupid Limited (the Company) have been reviewed and recommended for approval by the Audit Committee to the Board of Directors and have been approved by the Board of Directors at its meeting held on 7 August, 2026. 3. The Chief Operating Decision Maker (CODM), evaluates the company s performance and allocates resources based on the analysis of the various performance indicators of the Company as a single unit. The Company is engaged in manufacturing and trading of Personal Care Products. Accordingly, the Company has only one reportable segment Personal care and disclosures as per Ind AS 108 Operating Segments are not applicable. 4. The Company has made a long-term strategic investment in Baazar Style Retail Limited by subscribing to its fully convertible warrants to be converted into equity share within 18 months from the date of issue. The warrants and equity shares arising upon conversion thereof, represent one continuing strategic equity share investment. The Company has made an irrevocable election to measure this investment at fair value through Other Compre [Showing first 8,000 characters — download PDF for full document]